Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial

Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision label was updated to Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects deployment of a newer version of the page content and related resources.
    Difference
    0.0%
    Check dated 2026-05-15T23:52:42.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The study page’s displayed update/version information has been refreshed, showing newer last update dates and an updated revision identifier. No substantive details about the clinical trial itself appear to be changed.
    Difference
    0.1%
    Check dated 2026-04-24T17:11:41.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added the 2026 Clin J Am Soc Nephrol publication by Heerspink et al. to the study's publications. Replaced the 2025 online-ahead-of-print reference with the final article and updated the revision to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:41:29.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0. This change does not affect study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-03-19T22:23:54.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3; no study information appears to be altered.
    Difference
    0.0%
    Check dated 2026-03-12T20:15:32.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Added a new publication citation under Publications: 'Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy' (Clin J Am Soc Nephrol, 2025).
    Difference
    0.0%
    Check dated 2026-02-19T04:42:23.000Z thumbnail image

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.